DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Animal Healthcare Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering.
The global animal healthcare market is driven by increasing trend of pet adoption, and growing global consumption of meat and milk. The adoption of western culture and changing lifestyle in the developing countries, such as India and China, has increased the adoption of pet animals, which supports the growth of the animal healthcare market. Pet ownership is considered as status symbol in the developing countries. Cats and dogs are adopted by people for psychological and therapeutic benefits. The evolution of new animal diseases offers untapped opportunities for the animal healthcare market. One such disease is porcine epidemic diarrhea virus (PEDV), which is caused by corona virus, and leads to infection within the cell lining in the small intestine of pigs.
The trend of adopting pets is increasing globally, which is supporting the growth of the global animal healthcare market to some extent. The adoption of western culture and changing lifestyles in the developing countries, such as India and China, has increased the adoption of pet animals. One of the major status symbols observed in the developing countries is pet ownership.
Some of the major companies operating in the global animal healthcare market include Zoetis, Merck, Merial, Bayer, Virbac, Ceva Sante Animal S.A., Boehringer Ingelheim GmbH, Elanco, and Vetoquinol.
Key Topics Covered:
1. Research Scope & Methodology
4.Global Animal Healthcare Market Size And Forecast (2012-2022)
5.Global Animal Healthcare Market, By Geography
6.Global Animal Pharmaceuticals Market
7.Global Production Animal Healthcare Market
8.Global Companion Animal Healthcare Market
9.Competitive Positioning & Market Share Analysis
10.Company Profiles And Strategic Developments
For more information about this report visit http://www.researchandmarkets.com/research/jrqlkb/global_animal